These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Treatment of hemangioma in oral and maxillofacial region with pingyangmycin injection].
    Author: Wang C, Gao Q, Fu F, Wen Y, Dai X, Gong H, Lu X.
    Journal: Hua Xi Kou Qiang Yi Xue Za Zhi; 2000 Oct; 18(5):317-9. PubMed ID: 12539650.
    Abstract:
    OBJECTIVE: To investigate the indication and result in hemangioma in oral and maxillofacial region with Pingyangmycin injection. METHODS: 1282 patients (554 males and 728 females) with hemangioma in oral and maxillofacial region have been treated in our hospital during the 10-year period from May 1990 to March 1999. The patients range between 0.5-84 years old. Lip, cheek and tongue were usually involved. 1211 patients were treated with injection of Pingyangmycin(about 0.89 mg/ml) and dexamethasone (about 0.55 mg/ml), 1 time/1-2 weeks. RESULTS: The curative rates of cavernous hemangioma and strawberry hemangioma were 93.87% and 84.90%, but that of plexiform hemangioma was 22.22% and those of portwine stain and central hemangioma of the jaws were 0%, respectively. Serious complications associated with Pingyangmycin injection, such as pulmonary fibrosis were not seen. CONCLUSION: Injection of Pingyangmycin is selective primary method for cavernous and strawberry hemangioma treatment.
    [Abstract] [Full Text] [Related] [New Search]